1248576

Anna Hibbs, M.D. — FEI 3031225073

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 9, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional Details

Clinical Investigator (CI)